Abstract
The cadaveric renal graft is exposed to ischaemic injury during preservation and to oxidative damage during reperfusion. Both these mechanisms are known to cause cell damage, which may impair graft function. Reperfusion injury (RPI) is mediated by reactive oxygen species (ROS). Ascorbic acid (AA) is a potent physiological extracellular scavenger of ROS. We perfused 31 renal grafts immediately before implantation with a solution of Euro-Collins containing 0.5 mg/ml of AA to diminish RPI. From every donor, the contralateral kidney served as a control. The control grafts were perfused with the same perfusion as those of the AA group, only without the AA substitution. We assessed the effect of AA by recording serum creatinine, creatinine clearance, initial graft function and early rejections. The incidence of delayed graft function (DGF) was 32% in the AA group, and 29% in the control group. Other parameters were also similar in both groups, except for the length of DGF, which showed a trend towards a shorter duration in the AA group. The pre-operative systemic AA concentration was significantly (P=0.01) lower in the haemodialysis patients than in those on peritoneal dialysis. In conclusion, this clinical study could not demonstrate significant benefits of AA in renal transplantation.
Similar content being viewed by others
References
Cecka JM, Terasaki PI (1995) The UNOS scientific renal transplant registry. United Network for Organ Sharing. Clin Transpl 1–18
Crompton M, Ellinger H, Costi A (1988) Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255:357–360
Davenport A, Hopton M, Bolton C (1995) Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograft transplantation and the effect on early graft function. Clin Transplant 9:171–175
Dawidson IJ, Ar'Rajab A (1992) Perioperative fluid and drug therapy during cadaver kidney transplantation. Clin Transpl 267–284
Dingchao H, Zhiduan Q, Liye H, Xiaodong F (1994) The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg 42:276–278
Doppelfeld IS, Parnham MJ (1992) Experimental conditions determine effects of ascorbic acid on reperfusion injury: comparison of tissue damage with hemodynamic parameters in rat isolated hearts. Methods Find Exp Clin Pharmacol 14:419–430
Feldman HI, Gayner R, Berlin JA, Roth DA, Silibovsky R, Kushner S, Brayman KL, Burns JE, Kobrin SM, Friedman AL, Grossman RA (1996) Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 11:1306–1313
Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC (1988) Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 46:223–228
Hower R, Minor T, Schneeberger H, Theodorakis J, Rembold S, Illner WD, Hofmann GO, Fraunberger P, Isselhard W, Land W (1996) Assessment of oxygen radicals during kidney transplantation—effect of radical scavenger. Transpl Int [Suppl] 9:479–482
Humar A, Johnson EM, Payne WD, Wrenshall L, Sutherland DE, Najarian JS, Gillingham KJ, Matas AJ (1997) Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant 11:623–627
Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV (1998) Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 153:557–566
Kyllönen L, Salmela K (2000) Transplantation of both kidneys from 408 donors; comparison of results. Transpl Int [Suppl] 13:95–98
Kyllönen LE, Salmela KT, Eklund BH, Halme LE, Höckerstedt KA, Isoniemi HM, Mäkisalo HJ, Ahonen J (2000) Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int 13:122–128
Land W, Schneeberger H, Schleibner S, Illner WD, Abendroth D, Rutili G, Arfors KE, Messmer K (1994) The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 57:211–217
Lee KC, Hamel DW, Kunbel S (1993) Rodent model of renal ischemia and reperfusion injury: influence of body temperature, seasonal variation, tumor necrosis factor, endogenous and exogenous antioxidants. Methods Find Exp Clin Pharmacol 15:153–159
Lodge JP, Kashi SH, Lam FT, Lord A, Giles GR (1993) The reflush effect—a prospective analysis of late perfusion. Transplantation 55:567–572
Lykkesfeldt J, Loft S, Poulsen HE (1995) Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection—are they reliable biomarkers of oxidative stress? Anal Biochem 229:329–335
Marcen R, Orofino L, Pascual J, de la Cal MA, Teruel JL, Villafruela JJ, Rivera ME, Mampaso F, Burgos FJ, Ortuno J (1998) Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 66:461–466
Massoudy P, Mempel T, Raschke P, Becker BF (1999) Reduction of oxygen delivery during post-ischemic reperfusion protects the isolated guinea pig heart. Basic Res Cardiol 94:231–237
Masters TN, Fokin AA, Schaper J, Lorenz-Meyer S, Pool L, Gong G, Robicsek F (2000) Extending myocardial viability during heart preservation with cyclosporine A. J Card Surg 15:392–402
Nakagawa K, Koo DD, Davies DR, Gray DW, McLaren AJ, Welsh KI, Morris PJ, Fuggle SV (2002) Lecithinized superoxide dismutase reduces cold ischemia-induced chronic allograft dysfunction. Kidney Int 61:1160–1169
Niki E (1991) Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am J Clin Nutr [Suppl] 54:1119–1124
Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL (1997) Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63:968–974
Perez Fontan M, Rodriguez-Carmona A, Bouza P, Valdes F (1998) The prognostic significance of acute renal failure after renal transplantation in patients treated with cyclosporin. QJM 91:27–40
Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI (1998) Delayed graft function after renal transplantation. Transplantation 65:219–223
Ponka A, Kuhlback B (1983) Serum ascorbic acid in patients undergoing chronic hemodialysis. Acta Med Scand 213:305–307
Roake JA, Fawcett J, Koo DD, Fuggle SV, Gray DW, Morris PJ (1996) Late reflush in clinical renal transplantation. Protection against delayed graft function not observed. Transplantation 62:114–116
Rosenthal JT, Danovitch GM, Wilkinson A, Ettenger RB (1991) The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 51:1115–1118
Shah GM, Ross EA, Sabo A, Pichon M, Bhagavan H, Reynolds RD (1991) Ascorbic acid supplements in patients receiving chronic peritoneal dialysis. Am J Kidney Dis 18:84–90
Togashi H, Shinzawa H, Yong H, Takahashi T, Noda H, Oikawa K, Kamada H (1994) Ascorbic acid radical, superoxide, and hydroxyl radical are detected in reperfusion injury of rat liver using electron spin resonance spectroscopy. Arch Biochem Biophys 308:1–7
Troppmann C, Gillingham KJ, Gruessner RW, Dunn DL, Payne WD, Najarian JS, Matas AJ (1996) Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 61:1331–1337
Tsapas G, Magoula I, Paletas K, Concouris L (1983) Effect of peritoneal dialysis on plasma levels of ascorbic acid. Nephron 33:34–37
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Norio, K., Wikström, M., Salmela, K. et al. Ascorbic acid against reperfusion injury in human renal transplantation. Transpl Int 16, 578–583 (2003). https://doi.org/10.1007/s00147-003-0588-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00147-003-0588-0